Please set your pop-up blockers to allow pop-ups on We use pop-ups to display content. Click Help for more information.

2014-07-31 inReview: Assessing the Future of Therapy for B-Cell Malignancies: New Options, Novel Targets, and Implications for Care
Course Director
Jonathan W. Friedberg, MD, MMSc
James P. Wilmot Cancer Institute
University of Rochester Medical Center
Rochester, New York
2014-07-28 inReview: The Present and Future of Individualized Management of Metastatic CRPC: Expert Perspectives on the Challenges, Opportunities, and Practicalities
Course Director
Johann S. de Bono, MBChB, PhD, MSc
Institute of Cancer Research
Royal Marsden NHS Foundation Trust
Sutton, United Kingdom
2014-07-14 onDemand: Blending the Science and Art of Medicine in the Individualized Treatment of mCRPC: Real Cases, Difficult Choices—You Make the Call
Course Director
Robert Dreicer, MD, MS, FACP, FASCO
Taussig Cancer Institute
Cleveland Clinic
Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio
2014-06-30 onDemand: Community-Expert Conversations in Pancreatic Adenocarcinoma: New Therapies and Novel Concepts for Daily Practice
Course Director
Margaret A. Tempero, MD
UCSF Pancreas Center
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California
2014-06-25 inExchange: The Hematology-Oncology Team in Myelofibrosis: Best Practices for Enhancing Patient Care
Course Director
John Mascarenhas, MD
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, New York
2014-06-18 PeerView Live: Head and Neck Cancer and HPV Status: New Insights Into Prognosis, Treatment Goals, and Patient Care
Course Director
Maura L. Gillison, MD, PhD
The Ohio State University
Columbus, Ohio
2014-06-03 inReview: New Targets, Novel Options in Mantle Cell Lymphoma: An Increasing Role for Innovative Therapy
Course Director
Christopher R. Flowers, MD, MS
Winship Cancer Institute
Emory University
Atlanta, Georgia
2014-06-02 inReview: Antifungal Pharmacology: Practical Considerations to Maximize Therapeutic Benefit and Tolerability
Course Director
Dimitrios P. Kontoyiannis, MD, MS, ScD, FACP, FIDSA
The University of Texas MD Anderson Cancer Center
Baylor College of Medicine
University of Houston
Houston, Texas
2014-05-16 inReview: Assessing the State of Established and Emerging Therapy in Relapsed/Refractory Myeloma
Course Director
Robert Z. Orlowski, MD, PhD
University of Texas MD Anderson Cancer Center
Houston, Texas
2014-05-14 inExchange: The Present and Future of Polycythemia Vera: Interdisciplinary Approaches to Patient-Centered Care
Course Director
Ruben A. Mesa, MD, FACP
Mayo Clinic in Arizona
Mayo Clinic Cancer Center
Scottsdale, Arizona